Table: Rohto -2018/19 group results

Rohto Pharmaceutical

10/05/2019 07:00

May 10 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            183.58          171.74         184.00                 
                 (+6.9 pct)      (+11.1 pct)    (+0.2 pct)               
  Operating         20.81           19.09          21.50                 
                 (+9.0 pct)      (+23.5 pct)    (+3.3 pct)               
  Recurring         18.97           18.85          21.30                 
                 (+0.6 pct)      (+18.1 pct)    (+12.3 pct)              
  Net
  Net                9.80            9.29          13.50                 
                 (+5.5 pct)      (-7.2 pct)     (+37.8 pct)              
  EPS             86.00 yen       81.55 yen     118.45 yen               
  EPS Diluted     85.66 yen       81.20 yen                              
  Ann Div         25.00 yen       22.00 yen      26.00 yen               
  -Q2 Div         11.00 yen       11.00 yen      13.00 yen               
  -Q4 Div         14.00 yen       11.00 yen      13.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T